SEC Form 4 · accession 0001171843-15-006652
IMMUNOMEDICS INC · IMMU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Don C Stark
Director
Period of report
Dec 1, 2015
Accepted (ET)
Dec 4, 2015 · 8:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000722830
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 1, 2015 | M | 10,000 | $1.59 | A | 50,450 | D | |
| Common Stock | Dec 1, 2015 | S | 5,100 | $3.155 | D | 45,350 | D | |
| Common StockF1 | Dec 1, 2015 | M | 10,664 | — | A | 56,014 | D | |
| Common StockF2 | Dec 1, 2015 | F | 4,229 | — | D | 51,748 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F3 | $1.59 | Dec 1, 2015 | M | 10,000 | D | — | Dec 3, 2015 | Common Stock, par value $0.01 per share | 10,000 | 0 | D |
| Restricted Stock UnitsF4 | — | Dec 1, 2015 | M | 10,664 | D | — | — | Common Stock, par value $0.01 per share | 10,664 | 0 | D |
| Stock Options (right to buy)F3 | $3.11 | Dec 2, 2015 | A | 28,821 | A | — | Dec 2, 2022 | Common Stock, par value $0.01 per share | 28,821 | 28,821 | D |
| Restricted Stock UnitsF4 | — | Dec 2, 2015 | A | 14,469 | A | — | — | Common Stock, par value $0.01 per share | 14,469 | 14,469 | D |
Explanation of responses
- F1Delivery of common stock upon vesting of restricted stock units granted on December 3, 2014.
- F2The number of shares withheld to satisfy the tax withholding obligation of the reporting person upon vesting of Restricted Stock Units is correlated with the reporting person's tax withholding percentage.
- F3The stock options are fully vested on the date of grant.
- F4Each restricted stock unit represents a contingent right to receive one share of Immunomedics, Inc. common stock. The restricted stock units shall vest upon the earlier of (i) the reporting person's completion of one year of service as a non-employee director from the date of grant, or (ii) the reporting person's continuation in service through the day immediately preceding the next annual stockholders meeting following the date of grant.